The George Washington University was selected as one of approximately 25 sites across the United States to launch a Phase II study for its adjuvanted recombinant protein-based COVID-19 vaccine candidate.
Kevin O'Connor, DO, associate professor of health, human function, and rehabilitation sciences, and of medicine at the School of Medicine and Health Sciences, to serve as the Physician to the President.
